HENDERA
831152
Hengerda New Materials
300946
Fujian Nebula Electronics.,Ltd
300648
4
Cubic Digital Technology
300344
5
HNAC Technology
300490
US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 3.0200
- -0.0900-2.89%
Close Feb 14 16:00 ET
- 3.0300
- +0.0100+0.33%
Post 20:01 ET
204.11MMarket Cap-2.03P/E (TTM)
3.2100High2.9950Low491.61KVolume3.1000Open3.1100Pre Close1.52MTurnover1.11%Turnover RatioLossP/E (Static)67.59MShares19.050052wk High0.62P/B134.41MFloat Cap2.700052wk Low--Dividend TTM44.51MShs Float85.0000Historical High--Div YieldTTM6.91%Amplitude0.0300Historical Low3.0820Avg Price1Lot Size
About Perspective Therapeutics Company
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Company Profile
SymbolCATX
Company NamePerspective Therapeutics
Listing DateApr 19, 2007
Founded1983
CEOMr. Johan M. Spoor
MarketAMEX
Employees119
Fiscal Year Ends12-31
Address2401 Elliott Avenue,Suite 320
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98121
Phone1-206-676-0900
Company Executives
- Name
- Position
- Salary
- Johan M. Spoor
- Director and Chief Executive Officer
- 1.46M
- Jonathan R. Hunt
- Chief Accounting Officer
- 1.17M
- Juan Graham
- Chief Financial Officer
- --
- Dr. Markus Puhlmann, M.D.,PhD
- Chief Medical Officer
- 900.09K
- Lori A. Woods
- Chairman of the Board
- 671.73K
- Robert Froman Willian, III
- Independent Director
- 320.06K
- Dr. Frank Morich, M.D.,PhD
- Independent Director
- 320.06K
- Heidi Henson, C.P.A.
- Independent Director
- 390.70K
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!